Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: 1.15 (7.03%)
Spread: 1.00 (5.882%)
Open: 16.35
High: 17.90
Low: 17.00
Prev. Close: 16.35
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with Smiths Medical

1 Dec 2006 12:23

Inditherm PLC01 December 2006 Press Release 1 December 2006 Inditherm plc ("Inditherm" or "The Company") US Distributorship Agreement with Smiths Medical Critical Care Inditherm plc (AIM: IDM), the provider of innovative heating solutions to thefood, industrial process, utility, medical, construction and sport industries,has signed an exclusive distribution agreement with Smiths Medical CriticalCare, (a Division of Smiths Medical), to distribute Inditherm's patient warmingproducts in the USA. Smiths Medical is a division of Smiths Group plc (FTSE:SMIN.L). Under this agreement, which has a term of at least 3 years, Smiths Medical willsell Inditherm heated mattresses and blankets under their Level 1(R) brand nameto the US medical market. The Inditherm products complement Smiths Medicals'existing range and can be used in a variety of areas, including operating rooms,pre- and post- operative areas and intensive care units. Inditherm's patient warming products are based upon The Company's unique,patented, low voltage conductive polymer technology, which provides uniform,direct heating, resulting in much better thermal transfer performance andadvantages over traditional patient warming methods. Smiths Medical has a well-established market presence in the US patient warmingsector with a large sales team, directed at hospitals throughout the US. Underthe terms of the agreement, sales are targeted to reach up to US$5million in thethird year. Smiths Medical Critical Care has undertaken to place an immediate order forheating mattresses worth at least $275,000 for demonstration stock. These willbe used for sales training early in the New Year and for demonstrations to andevaluations by potential customers. Commenting on the agreement, Inditherm's CEO, Richard Harpum said: "This is amajor step forward for Inditherm and a solid endorsement of our patient warmingtechnology by a world leader in medical products. Smiths Medical makes anexcellent partner, as they have the capability to accelerate our entry into theUS market". As stated in the Company's interim results on 28th September this year, therehas been encouraging progress made across all of the Company's core businessareas, although additional funds are required to continue the development. TheBoard is pursuing various strategic options to secure such funding. - Ends - For further information contact: Inditherm plcRichard Harpum, CEO +44 (0) 1709 761000rharpum@indithermplc.com www.inditherm.comIan Smith, Finance Director +44 (0) 1709 761000ismith@indithermplc.comAbchurchJustin Heath +44 (0) 113 203 1340justin.heath@abchurch-group.com www.abchurch-group.com Editors' Notes Inditherm plc Inditherm plc is an AIM-listed provider of low voltage, cost-effective heatingtechnology. It manufactures, installs and licenses its specialised, patentedheating technology for use in numerous applications that require temperaturemaintenance or frost protection, including industrial, utility, medical,construction, and sports turf heating. The Rotherham-based company operates ina global environment and has a blue-chip customer base. Inditherm's technology uses a carbon-based, electrically conductive polymer,also called Inditherm, to produce a cost-effective, flexible and adaptableheating surface. Powered by a low voltage supply, Inditherm generates uniformheat over its entire surface with no hot spots. Inditherm received US Food & Drug Administration clearance for its patientwarming products In May 2006. Smiths Medical Smiths Medical, a division of Smiths Group plc (LSE: SMIN.L) is aclinically-focused global leader in the design, manufacture, and distribution ofmedical devices used for a variety of therapeutic, diagnostic, and surgicalprocedures. The company's portfolio includes airway management, pain management,temperature management systems, infusion systems, implantable access systems,safety I.V. catheters, critical care monitoring, and insulin delivery systems.This product range offers customers clinical and economical advantages backed byexperience, innovation, and value-added services, including extensive producttraining and support. For more information, please visit http://www.smiths-medical.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Jun 20217:00 amRNSCapital Markets Day
28th May 20217:00 amRNSAnnual Report 2021 and Notice of AGM
20th May 20212:15 pmRNSMello Healthcare Presentation 25th May 2021
17th May 20217:00 amRNS£1.25m Ventilator Order received from China
29th Apr 20217:00 amRNSQueen’s Award for Enterprise for SLE Ltd
29th Apr 20217:00 amRNSTR1 Notification
27th Apr 20217:00 amRNSFinal Results
21st Apr 20217:00 amRNSSLE 6000 & OxyGenie® China approval &250k Order
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
29th Mar 20217:00 amRNSDistribution Agreement and MoU
16th Mar 20217:00 amRNSSLE 6000 & OxyGenie® Japan approval & £400k Order
23rd Feb 20212:10 pmRNSSecond Price Monitoring Extn
23rd Feb 20212:01 pmRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn
23rd Feb 202111:01 amRNSPrice Monitoring Extension
18th Feb 20217:00 amRNSResults date and post period end update
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
15th Feb 20212:06 pmRNSSecond Price Monitoring Extn
15th Feb 20212:00 pmRNSPrice Monitoring Extension
15th Feb 202111:06 amRNSSecond Price Monitoring Extn
15th Feb 202111:01 amRNSPrice Monitoring Extension
15th Feb 20219:06 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20212:06 pmRNSSecond Price Monitoring Extn
11th Feb 20212:01 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSRevenue and Profit Upgrade
21st Jan 20217:00 amRNSExercise of options and Total Voting Rights
14th Jan 20217:00 amRNSTR1 Notification
2nd Dec 20207:00 amRNSEuropean Patent granted for Project WAVE
1st Dec 20201:16 pmRNSInspiration wins AIM Transaction of the Year Award
16th Nov 20207:00 amRNSProject WAVE MHRA Approval
29th Oct 20207:00 amRNSAppointment of Non-Executive Director
6th Oct 20207:00 amRNSInterim Results
23rd Sep 20207:00 amRNSAppointment of Dr. Peter Reynolds
22nd Sep 20207:00 amRNSNotice of Results and Nomination for AIM Awards
16th Sep 20207:00 amRNSVentilator deliveries total £7 million
10th Sep 20203:44 pmRNSTR1 Notification
8th Sep 20207:00 amRNSProject Wave- IRAS submission
26th Aug 202012:12 pmRNSTR1 Notification
20th Aug 20207:00 amRNSUpdate on Ventilator Delivery to the NHS
11th Aug 20207:00 amRNSTrading Update
29th Jul 202011:58 amRNSTR1 Notification
9th Jul 20201:32 pmRNSTR1 Notification
9th Jul 202011:20 amRNSTR1 Notification
9th Jul 202011:17 amRNSTR1 Notification
9th Jul 202011:16 amRNSTR1 Notification
9th Jul 202011:15 amRNSTR1 Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.